Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) less than or equal to .
Blood coagulation parameters: international normalized ration (INR) =< .
Adequate coagulation tests: international normalized ratio ?.
Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) less than or equal to .
Coagulation: International normalized ratio (INR) ?. within  days of starting study.
Adequate blood coagulation function defined by International Normalized Ratio (INR) ?. (except for participants on warfarin therapy where INR must be ?. prior to randomization)
International Normalized Ratio (INR) for coagulation above upper normal range
Subject who has a clinically significant coagulation disorder or disease, defined as a platelet count <, per microliter, International Normalized Ratio >., or a PTT more than . times outside the laboratory's normal reference range;
Normal coagulation defined as normal International Normalized Ratio (INR) or per institutional guidelines.
Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) ?.
International normalized ratio (INR) <  if off of anti-coagulation; patients on anti-coagulation therapy with an INR >  may be enrolled at the discretion of the investigator if they have not had any episodes of severe hemorrhage
The patient must have adequate coagulation function as defined by international normalized ratio (INR) =< . and
All patients should have normal coagulation, with international normalized ratio (INR) < . and able to withhold anti-coagulation medications a minimum of  hours prior to radiosurgery (or until INR normalizes), on the day of treatment and  hours after radiosurgery has concluded; those patients getting WBRT may continue these medications
Adequate coagulation: international normalised ratio (INR) ?. for patients on anti-coagulation therapy
Patients should have normal coagulation [International Normalized Ratio (INR) < .] and be able to withhold anticoagulation/antiplatelet medications a minimum of  hours prior to radiosurgery treatment (or until INR normalizes), on the day of treatment and  hours after radiosurgery treatment has concluded.
Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) ? ..
Coagulation: International Normalized Ratio (INR) ? .
Coagulation: International Normalized Ratio (INR) ? .
Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) less than or equal to ..
Adequate blood coagulation function, defined as international normalized ratio (INR) less than or equal to .
Severely abnormal coagulation (INR>.)
Subject has a clinically significant coagulation disorder or disease, defined as a platelet count < , per microliter or International Normalized Ratio > . within  weeks of surgery;
International normalized ratio (INR) =< . unless using warfarin for therapeutic anti-coagulation
International normalized ratio (INR) =< .; patients are eligible if elevated INR is due to anti-coagulation medications and will need to provide documentation of stable coagulation parameters prior to study entry
Adequate coagulation parameters, defined as international normalization ratio (INR) ?
Coagulation: International Normalized Ratio (INR) ? .
International normalized ratio (INR) =< . x ULN; patients receiving anti-coagulation therapy are permitted as long as they have a stable INR =< .
International normalized ratio (INR) < . x ULN unless patients are receiving anti-coagulation therapy; patients receiving anti-coagulation therapy with an agent such as warfarin or heparin are allowed to participate if INR =< .
Abnormal coagulation parameters (international normalized ratio [INR] > . not on Coumadin, or platelet count < ,)
Severely abnormal coagulation (INR>.)
Adequate blood coagulation as evidenced by an International Normalized Ratio (INR) ?..
Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) ?..